Standard BioTools Inc. (LAB) News
Filter LAB News Items
LAB News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
LAB News Highlights
- For LAB, its 30 day story count is now at 6.
- Over the past 16 days, the trend for LAB's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- DEC, SLGC and GOLD are the most mentioned tickers in articles about LAB.
Latest LAB News From Around the Web
Below are the latest news stories about STANDARD BIOTOOLS INC that investors may wish to consider to help them evaluate LAB as an investment opportunity.
Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioToolsDr. Larry Gold, the founder of SomaLogic, Inc. ("SomaLogic" or the "Company") (Nasdaq: SLGC) and Dr. Jason Cleveland, SomaLogic's current Chief Technology Officer, are issuing the below letter to SomaLogic's stockholders regarding their opposition to the Company's proposed merger with Standard BioTools, Inc. ("Standard") (Nasdaq: LAB). |
SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading DisclosureSomaLogic, Inc. (Nasdaq: SLGC), a leader in proteomics technology, today issued the following statement in response to a press release issued by Madryn Asset Management, LP ("Madryn") on December 26, 2023, regarding the pending merger with Standard BioTools (Nasdaq: LAB): |
ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogicSOUTH SAN FRANCISCO, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health - today announced that leading independent proxy advisory firm Institutional Shareholder Services (“ISS”) has recommended that Standard BioTools stockholders vote “FOR” all proposals relating to the pending merger with SomaLogic at the Company’s upcoming Special Meeting of Stockholders to be held on January 4, |
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioToolsCombination Builds Scale and Accelerates Path to Profitability, Unlocking Significant Potential Value for SomaLogic Stockholders Madryn’s Concerns are Not Based on Facts, and Madryn Selectively Ignores Risks in a Standalone Strategy and Potential Benefits of the Merger Urges Stockholders to Vote “FOR” Merger Ahead of Special Meeting of Stockholders on January 4, 2024 BOULDER, Colo., Dec. 21, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc. (Nasdaq: SLGC) today issued an open letter to stockholders highl |
Skye Fund III Issues Letter Regarding Opposition to SomaLogic’s Proposed Merger with Standard BioToolsBelieves that the Proposed Merger Grossly Undervalues SomaLogic and Ignores its Revolutionary Products, Considerable Cash Position, and Strong Balance Sheet Iterates that SomaLogic can Thrive as a Standalone Enterprise and Does Not Need Standard BioTools to Thrive Expresses Serious Concerns with Other Aspects of the Proposed Merger, including Potential Conflicts of Interest BALTIMORE, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Skye Fund III, which together with its affiliates, owns approximately 3.4 mill |
SomaLogic Shareholder Madryn Opposes Standard BioTools Merger(Bloomberg) -- SomaLogic Inc. shareholder Madryn Asset Management plans to vote against the clinical diagnostics group’s merger with Standard BioTools Inc. and is urging other investors to do the same.Most Read from BloombergJPMorgan Is in a Fight Over Its Client’s Lost $50 Million FortuneGoldman Trader Paid $100 Million Since 2020 Is Stepping DownArgentina’s Milei Devalues Peso by 54% in First Batch of Shock MeasuresNetflix Posts Viewer Data on Every Show, Film for First TimeRaimondo Vows ‘Stro |
Standard BioTools and SomaLogic Announce Date for Special Meetings of Stockholders to Vote on Proposed MergerSOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – and SomaLogic, Inc. (Nasdaq: SLGC), a leader in data-driven proteomics technology, today announced that the companies have set a date for their respective Special Meetings of Stockholders in connection with the pending all-stock merger which was previously announced on October 4, 2023. Eac |
Standard BioTools Inc. (NASDAQ:LAB) has caught the attention of institutional investors who hold a sizeable 44% stakeKey Insights Significantly high institutional ownership implies Standard BioTools' stock price is sensitive to their... |
Q3 2023 Somalogic Inc Earnings CallQ3 2023 Somalogic Inc Earnings Call |
Standard BioTools Inc. (NASDAQ:LAB) Q3 2023 Earnings Call TranscriptStandard BioTools Inc. (NASDAQ:LAB) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Hello, and welcome to the Standard BioTools’ Third Quarter 2023 Financial Results Conference Call. As a reminder this conference is being recorded. It is now my pleasure to introduce your host Peter DeNardo, Investor Relations. Thank you. Mr. DeNardo, you may begin. […] |